Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic
Top Cited Papers
- 2 April 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Reviews Clinical Oncology
- Vol. 17 (5), 268-270
- https://doi.org/10.1038/s41571-020-0362-6
Abstract
During the COVID-19 global pandemic, the cancer community faces many difficult questions. We will first discuss safety considerations for patients with cancer requiring treatment in SARS-CoV-2 endemic areas. We will then discuss a general framework for prioritizing cancer care, emphasizing the precautionary principle in decision making.Keywords
This publication has 7 references indexed in Scilit:
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefitsRadiotherapy and Oncology, 2018
- The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysisBreast Cancer Research and Treatment, 2016
- Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal CancerJAMA, 2011
- The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literatureRadiotherapy and Oncology, 2008